润都股份：关于氢氯噻嗪获得化学原料药上市申请批准通知书的公告

Group 1 - The core point of the article is that Rundu Co., Ltd. has received approval from the National Medical Products Administration for the listing application of hydrochlorothiazide as a chemical raw material drug [2] Group 2 - The announcement was made on the evening of August 19, indicating a significant regulatory milestone for the company [2] - The approval is expected to enhance the company's product portfolio and market position in the pharmaceutical industry [2]